Biomedical knowledge graph
A knowledge graph where every link opens on its sources.
Atlas reads the papers in your project, extracts drugs, diseases, genes and endpoints, and links them. Each relationship carries the passages it was drawn from, so you can check it in one click instead of trusting it.
- papers read from the project corpus
- 421
- entities extracted
- 40
- relationships between them
- 297
- papers behind the adagrasib and brain metastases link
- 6
Step 1 of 3
Entities come out of your corpus, typed
Drugs, diseases, genes, proteins, clinical endpoints and pathways, named the way the papers name them. Nothing is added from outside the project.
Drugs found: sotorasib, adagrasib, divarasib, olomorasib, docetaxel, cetuximab, and the class “KRAS G12C inhibitors”.
Step 2 of 3
Links are weighted by how many papers support them
A thick line is a relationship many papers describe. A thin one rests on one or two, and you see that before you rely on it.
Hover a line for its count. Highlighted: adagrasib and brain metastases, opened below.
Step 3 of 3
Open a link and read the passages behind it
Each piece of evidence points to a paper in your corpus, with the passage Atlas drew the relationship from. From there, the Atlas Copilot can go further on the same papers.
- 2025
Multicenter study of the impact of trial eligibility criteria on enrollment to KRAS G12C inhibitor trials
Journal of Clinical Oncology
Retrospective multicenter review of 185 patients with KRAS G12C-mutant advanced NSCLC.
- 2026
Evaluating the efficacy of G12C inhibitors in conjunction with Gamma Knife radiosurgery
Journal of Neuro-Oncology
61 NSCLC patients with KRAS mutations, including 33 G12C-mutated, treated with Gamma Knife radiosurgery.
- 2025
Matching-adjusted indirect comparison of sotorasib versus adagrasib in previously treated advanced NSCLC
Advances in Therapy
- +33 more papers, 2022 to 2026
Build the graph of your own indication
We set up a project on your disease and target with you, and walk through the graph together.
Request a demoExample project: KRAS G12C · non-small cell lung cancer, built in Atlas on 10 Oct 2026. Counts are those of the project graph on that date.